Skip to main content
Clinical Trials/NCT05411848
NCT05411848
Completed
Not Applicable

Evaluation of a Nutritionally Complete, Plant-based, High Energy, High Protein, Enteral Tube Feed in Adults

Nutricia UK Ltd1 site in 1 country42 target enrollmentMay 17, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Enteral Nutrition
Sponsor
Nutricia UK Ltd
Enrollment
42
Locations
1
Primary Endpoint
Change in gastrointestinal tolerance
Status
Completed
Last Updated
last year

Overview

Brief Summary

The primary aim of this study is to investigate the effects of a plant-based, high energy, high protein tube feed with and without inclusion of fibre on gastrointestinal tolerance in adult patients who require nutritional support via enteral tube feeding over a 28-day period, followed by a 12-month follow-up. Secondary aims are to determine the effects on compliance, acceptability, anthropometry, nutrient intake, and physical function. This is a prospective, longitudinal, 28-day intervention study with a 1-day baseline period and a 1-year follow-up.

Registry
clinicaltrials.gov
Start Date
May 17, 2022
End Date
December 15, 2023
Last Updated
last year
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Male or female
  • ≥16 years of age
  • Using or requiring an enteral tube feed in the community as part of nutritional management plan
  • Expected to receive at least 1000kcal/day (one bottle) from one of the study products

Exclusion Criteria

  • Receiving parenteral nutrition
  • Patients with major hepatic dysfunction (i.e., decompensated liver disease)
  • Patients with major renal dysfunction (i.e., requiring filtration or stage 4/5 chronic kidney disease (CKD))
  • Patients receiving inpatient care
  • Known pregnancy or lactation
  • Participation in other clinical intervention studies within 1 month of this study
  • Allergy to any study product ingredients
  • Investigator concern regarding ability or willingness of patient to comply with the study requirements.

Outcomes

Primary Outcomes

Change in gastrointestinal tolerance

Time Frame: Change from baseline (Day 1) to end of follow-up (12 months)

A standardised gastrointestinal (GI) tolerance questionnaire to capture perceived severity

Secondary Outcomes

  • Acceptability(Baseline to end of intervention (7-28 days) and end of follow-up (12 months))
  • Anthropometry(Baseline to end of intervention (7-28 days) and end of follow-up (12 months))
  • Dietetic goal(Baseline to end of intervention (7-28 days) and end of follow-up (12 months))
  • Safety (Adverse events)(Baseline to end of intervention (7-28 days) and end of follow-up (12 months))
  • Handgrip strength(6-months to 12-months follow-up)
  • Compliance(Baseline to end of intervention (7-28 days) and end of follow-up (12 months))
  • Calf circumference(6-months to 12-months follow-up)
  • 30-s Chair Stand Test(6-months to 12-months follow-up)
  • Dietary intake(Baseline to end of intervention (7-28 days) and end of follow-up (12 months))

Study Sites (1)

Loading locations...

Similar Trials